These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 109196)

  • 1. Variable oral absorption of hexamethylmelamine in man.
    D'Incalci M; Bolis G; Mangioni C; Morasca L; Garattini S
    Cancer Treat Rep; 1978 Dec; 62(12):2117-9. PubMed ID: 109196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I and clinical pharmacological evaluation of a parenteral hexamethylmelamine formulation.
    Ames MM; Richardson RL; Kovach JS; Moertel CG; O'Connell MJ
    Cancer Res; 1990 Jan; 50(1):206-10. PubMed ID: 2104537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I trial of pentamethylmelamine: a clinical and pharmacologic study.
    Ihde DC; Dutcher JS; Young RC; Cordes RS; Barlock AL; Hubbard SM; Jones RB; Boyd MR
    Cancer Treat Rep; 1981; 65(9-10):755-62. PubMed ID: 6791819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of hexamethylmelamine and pentamethylmelamine in mice.
    Broggini M; Colombo T; D'Incalci M; Donnelli MG; Gescher A; Garattini S
    Cancer Treat Rep; 1981; 65(7-8):669-72. PubMed ID: 6788370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A sensitive and specific assay for pentamethylmelamine in plasma: applicability to clinical studies.
    Dutcher JS; Jones RB; Boyd MR
    Cancer Treat Rep; 1980 Jan; 64(1):99-104. PubMed ID: 6769585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hexamethylmelamine distribution in patients with ovarian and other pelvic cancers.
    D'Incalci M; Farina P; Sessa C; Mangioni C; Garattini S
    Cancer Treat Rep; 1982 Feb; 66(2):231-5. PubMed ID: 6799199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altretamine (hexamethylmelamine) in platinum-resistant and platinum-refractory ovarian cancer: a Gynecologic Oncology Group phase II trial.
    Markman M; Blessing JA; Moore D; Ball H; Lentz SS
    Gynecol Oncol; 1998 Jun; 69(3):226-9. PubMed ID: 9648592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of satraplatin (JM216), an oral platinum (IV) complex under daily oral administration for 5 or 14 days.
    Vouillamoz-Lorenz S; Buclin T; Lejeune F; Bauer J; Leyvraz S; Decosterd LA
    Anticancer Res; 2003; 23(3C):2757-65. PubMed ID: 12926110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid and blood concentrations of toltrazuril 5% suspension in the horse after oral dosing.
    Furr M; Kennedy T
    Vet Ther; 2000; 1(2):125-32. PubMed ID: 19757559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hexamethylmelamine in ovarian cancer resistant to cyclophosphamide and adriamycin.
    Bolis G; D'Incalci M; Belloni C; Mangioni C
    Cancer Treat Rep; 1979 Aug; 63(8):1375-7. PubMed ID: 113096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of hexamethylmelamine administered via the Ip route in an oil emulsion vehicle.
    Wickes AD; Howell SB
    Cancer Treat Rep; 1985 Jun; 69(6):657-62. PubMed ID: 3926309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of recombinant human interleukin 3 administered subcutaneously and by continuous intravenous infusion in patients after chemotherapy for ovarian cancer.
    Biesma B; Pokorny R; Kovarik JM; Duffy FA; Willemse PH; Mulder NH; de Vries EG
    Cancer Res; 1993 Dec; 53(24):5915-9. PubMed ID: 8261403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hexamethylmelamine and pentamethylmelamine tissue distribution in M5076/73A ovarian cancer-bearing mice.
    Broggini M; Rossi C; Colombo T; D'Incalci M
    Cancer Treat Rep; 1982 Jan; 66(1):127-33. PubMed ID: 6796267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early clinical trial of a 1-day intermittent schedule for pentamethylmelamine.
    Eagan RT; Creagan ET; Rubin J; O'Connell MJ; Kovach JS
    Cancer Treat Rep; 1980; 64(8-9):993-5. PubMed ID: 6778613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hexamethylmelamine, doxorubicin, and cyclophosphamide in advanced ovarian cancer resistant to previous chemotherapy.
    Sessa C; Bolis G; Valente I; Mangioni C; D'Incalci M
    Cancer Treat Rep; 1981; 65(1-2):172-3. PubMed ID: 6784922
    [No Abstract]   [Full Text] [Related]  

  • 17. Low oral bioavailability of hexamethylmelamine in the rat due to simultaneous hepatic and intestinal metabolism.
    Klippert PJ; Hulshoff A; Mingels MJ; Hofman G; Noordhoek J
    Cancer Res; 1983 Jul; 43(7):3160-4. PubMed ID: 6406053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential intraperitoneal topotecan and oral etoposide chemotherapy in recurrent platinum-resistant ovarian carcinoma: results of a phase II trial.
    Sood AK; Lush R; Geisler JP; Shahin MS; Sanders L; Sullivan D; Buller RE; Sorosky JI
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6080-5. PubMed ID: 15447993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral topotecan given once or twice daily for ten days: a phase I pharmacology study in adult patients with solid tumors.
    Gerrits CJ; Burris H; Schellens JH; Eckardt JR; Planting AS; van der Burg ME; Rodriguez GI; Loos WJ; van Beurden V; Hudson I; Fields S; Von Hoff DD; Verweij J
    Clin Cancer Res; 1998 May; 4(5):1153-8. PubMed ID: 9607572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hexamethylmelamine and cisplatin in advanced ovarian cancer after failure of alkylating-agent therapy.
    Vogl SE; Pagano M; Davis TE; Einhorn N; Tunca JC; Kaplan BH; Arseneau JC
    Cancer Treat Rep; 1982 Jun; 66(6):1285-90. PubMed ID: 6282454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.